Qure.ai
Founded Year
2016Stage
Series C - II | AliveTotal Raised
$60.99MAbout Qure.ai
Qure.ai has developed an artificial intelligence-based system to identify abnormalities in head CT scans. The company aims to leverage deep learning effectively to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. It was founded in 2016 and is based in Mumbai, India.
Qure.ai Headquarter Location
Level 6, Oberoi Commerz II, Goregaon East
Mumbai, 400063,
India
+91 22 4067 5800
Qure.ai's Product Videos
ESPs containing Qure.ai
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Solutions that leverage machine learning and computer vision for image acquisition, disease detection, triaging, and diagnosis from ultrasounds, MRIs, CT scans, and more.
Qure.ai named as Outperformer among 9 other companies, including Viz.ai, Zebra Medical Vision, and Shukun Technology.
Qure.ai's Products & Differentiation
See Qure.ai's products and how their products differentiate from alternatives and competitors
qXR
can detect abnormal findings on a chest X-ray. Its is a CE-certified patented algorithms that can detect a total of 30 findings on the chest X-ray.
Differentiation
qXR has a sensitivity and specificity equivalent to expert radiologists. It can
assist radiologists by clustering their worklists into distinct buckets of Normal, Abnormal and To Be Reviewed.
It can also automate reporting with precise findings and quantification. It Is a great aid to manage long worklists, enhance reporting speed and prioritize cases that need immediate attention.
Key Value Deliverables
Seamlessly integrates with worklists across different PACS systems for reassignment & escalation.
Vendor agnostic integration.
Key Features
One of the Largest training dataset
Underlying convolutional neural networks trained with >5 Million scans, generalize well to new data. Clinically validated in multiple geographies.
Supports analog X-rays
Tested with X-rays from all major manufacturers (DR and CR)
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Differentiation
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Differentiation
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Differentiation
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Research containing Qure.ai
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Qure.ai in 8 CB Insights research briefs, most recently on Apr 4, 2022.
Expert Collections containing Qure.ai
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Qure.ai is included in 7 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
8,717 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
11,573 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Digital Health 150
300 items
The winners of the second annual CB Insights Digital Health 150.
Digital Hospital
198 items
Startups recreating how healthcare is delivered
Digital Health
12,808 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health IT
10,503 items
This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.
Qure.ai Patents
Qure.ai has filed 8 patents.
The 3 most popular patent topics include:
- Artificial neural networks
- Machine learning
- Medical imaging
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/13/2021 | 5/24/2022 | Natural language processing, Portable computers, Health informatics, Mobile computers, Personal computers | Grant |
Application Date | 10/13/2021 |
|---|---|
Grant Date | 5/24/2022 |
Title | |
Related Topics | Natural language processing, Portable computers, Health informatics, Mobile computers, Personal computers |
Status | Grant |
Latest Qure.ai News
Apr 21, 2022
Qure.ai gets financial support to develop AI-based lung screening software-Business Journal By Artificial intelligence player, Qure.ai is set to scale Artificial Intelligence (AI)-enabled chest X-ray screening software, qXR, at 50 locations across more than 15 states in India, an official statement said. The company has received a commitment of ₹2.45 crore or approx $350,000 from the US Agency for International Development (USAID)- supported SAMRIDH Healthcare Blended Financing Facility for developing this software. The software will enable healthcare workers in the dual screening of COVID-19 and lung diseases such as Tuberculosis, in remote and resource-challenged locations, and expected to benefit an estimated 62,500 people in the next 12-14 months. SAMRIDH is supported by USAID in technical collaboration with Atal Innovation Mission & Women Entrepreneurship, Niti Aayog among other participants and managed by international development consulting group – IPE Global. SAMRIDH offers both grant and debt financing provision to healthcare enterprises and innovators. Health-tech player Qure.ai builds AI-powered solutions focusing on pulmonary and neurocritical care to deliver better patient outcomes. Qure.ai’s CE-approved qXR software not only detects 30 critical lung abnormalities in under a minute, but also quantify the infection, giving healthcare workers real-time insights into disease progression. As a result, it provides instant diagnostic support and actionable insights for frontline healthcare workers while optimizing resources and strengthening community care. Prashant Warier, CEO and Founder of Qure.ai stated that the AI technology for chest X-ray screening and interpretation could improve the lives of patients and medical personnel. “Remote locations in India struggle for resources to deal with highly transmissible infectious diseases like Tuberculosis and COVID-19. Our AI solution will significantly improve diagnosis, treatment, and patient health,” he said. The company looks to the deployment of advanced healthcare solutions in more public health settings. Himanshu Sikka, Project Director, SAMRIDH commented that the software from Qure.ai “is faster, accurate, cost-effective, and will truly transform diagnostics in primary healthcare settings.” Published on
Qure.ai Web Traffic
Qure.ai Rank
When was Qure.ai founded?
Qure.ai was founded in 2016.
Where is Qure.ai's headquarters?
Qure.ai's headquarters is located at Level 6, Oberoi Commerz II, Goregaon East, Mumbai.
What is Qure.ai's latest funding round?
Qure.ai's latest funding round is Series C - II.
How much did Qure.ai raise?
Qure.ai raised a total of $60.99M.
Who are the investors of Qure.ai?
Investors of Qure.ai include Merck & Co., MassMutual Ventures, Novo Holdings, Healthquad, SBRI Healthcare and 6 more.
Who are Qure.ai's competitors?
Competitors of Qure.ai include Deeptek, Lunit, QUIBIM, Zebra Medical Vision, Aidoc Medical, VUNO, InMed Prognostics, mediaire, Kheiron Medical Technologies, Blue Eye Soft and 12 more.
What products does Qure.ai offer?
Qure.ai's products include qXR and 3 more.
Who are Qure.ai's customers?
Customers of Qure.ai include NHS Trusts and vRAD.
You May Also Like
Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work.
Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.
Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.
Kheiron Medical Technologies is a healthcare software company. Through its Machine Learning technology, it seeks to makes cancer diagnoses faster, easier, cheaper and more accurate. Its Deep Learning algorithms analyze medical images and its software uses the analysis results to enable the automation of radiology reporting tasks.
Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.
MaxQ AI is at the forefront of Medical Diagnostic AI. The company is transforming healthcare by empowering physicians to provide “smarter care” with AI-powered clinical insights. Based in Tel Aviv, Israel and Andover, MA, USA, MaxQ AI developed a software platform that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, the company's software enables caregivers to make faster, more accurate decisions when diagnosing stroke, traumatic brain injury and other serious conditions.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.